Seminars in Oncology

1

Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer

Dosia Antonadou, Aris Petridis, Maria Synodinou, Nicolas Throuvalas, Nicolas Bolanos, Marinos Veslemes, Alexandros Sagriotis

Journal:

Year:

2003

Language:

english

File:

PDF, 180 KB

english, 2003

2

Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine

K.S.Clifford Chao, Gokhan Ozyigit, Wade L Thorsdad

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

3

Feasibility of amifostine administration in conjunction with high-dose rate brachytherapy

Timothy Dziuk, Neil Senzer

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

4

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

Robert Haddad, Lori Wirth, Rosemary Costello, Linda Weeks, Marshall Posner

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 75 KB

english, 2003

5

Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer

Kenneth Hu, Jonathan A Ship, Louis B Harrison

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 255 KB

english, 2003

6

Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine?

Aminah Jatoi

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 65 KB

english, 2003

7

Amifostine: is there evidence of tumor protection?

Michael I Koukourakis

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

8

Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: preliminary results of a phase II trial

Luis A Linares, Deborah Echols

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 116 KB

english, 2003

9

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results

Cynthia Ménard, Kevin Camphausen, Thierry Muanza, Nancy Sears-Crouse, Sharon Smith, Edgar Ben-Josef, C.Norman Coleman

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 81 KB

english, 2003

10

Docetaxel with concurrent radiotherapy in head and neck cancer

Lisle Nabell, Sharon Spencer

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 115 KB

english, 2003

11

Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: overview of trial design

Michael A Samuels, Isagani M Chico, Robert L Hirsch, Keri Fullmer

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 54 KB

english, 2003

12

Cytoprotection/radioprotection with amifostine: potential role in cervical cancer and early findings in the radiation therapy oncology group C-0116 trial

William Small Jr

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 67 KB

english, 2003

13

Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary data

Wade L Thorstad, Bruce Haughey, K.S.Clifford Chao

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 77 KB

english, 2003

14

Effects of dose and schedule on the efficacy of Ethyol: preclinical studies

David R Cassatt, Christine A Fazenbaker, Gizachew Kifle, Christine M Bachy

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

15

The effect of oral mucositis on morbidity and mortality in bone marrow transplant

Don A Gabriel, Thomas Shea, Oludamilola Olajida, Jonathan S Serody, Terrance Comeau

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 97 KB

english, 2003

16

Introduction

Walter J. Curran Jr

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 37 KB

english, 2003

17

The third international cytoprotection investigators’ congress

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 24 KB

english, 2003

19

Radioprotective effect of amifostine in radiation pneumonitis

Noah C Choi

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 95 KB

english, 2003

Volume 30; Issue supp-S18

Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer

Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine

Feasibility of amifostine administration in conjunction with high-dose rate brachytherapy

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer

Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine?

Amifostine: is there evidence of tumor protection?

Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: preliminary results of a phase II trial

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results

Docetaxel with concurrent radiotherapy in head and neck cancer

Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: overview of trial design

Cytoprotection/radioprotection with amifostine: potential role in cervical cancer and early findings in the radiation therapy oncology group C-0116 trial

Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary data

Effects of dose and schedule on the efficacy of Ethyol: preclinical studies

The effect of oral mucositis on morbidity and mortality in bone marrow transplant

Introduction

Table of contents

The third international cytoprotection investigators’ congress

Radioprotective effect of amifostine in radiation pneumonitis